Enclosed herewith is the Certificate under SEBI (Depositories and Participants) Regulations, 2018 for quarter ended March 31, 2026.Kindly take the same on record.
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Supriya Lifescience has submitted a regulatory compliance certificate for Q4 FY2025-26 (quarter ended March 31, 2026). The certificate was issued by MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent. It confirms that all securities received for dematerialization during the quarter were properly processed, confirmed or rejected, and the related physical share certificates were mutilated and cancelled. The depositories were substituted as registered owners in the member register within prescribed timelines. This is a routine quarterly compliance filing required under SEBI regulations.
No direct impact on shareholders or stock price. This is a standard regulatory compliance filing confirming proper handling of share dematerialization processes. It indicates the company is following statutory requirements for share registry management.